Skip To Main Content
This website is intended exclusively for healthcare professionals residing and/or working in the KSA.
Campus
  • Payor
Campus
  • Payor

Inspiration and Innovation

Get inspired and stay on the cutting edge of innovation with these resources.

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content

Hear from an expert on would you consider a biologic for a Surgery-naïve Patient with CRS with Nasal Polyps?

Learn more

Hear From An Expert On What Does The Future Of Treatment Look Like For Crs With Nasal Polyps?

Learn more

Hear from an expert on how do you address Patients' concerns about Sinus surgery?

Learn more

T1D Treatment Practice and the SAGE Study

Learn more

Pneumology Meets Oto-Rhino-Laryngology: A Discussion of Type 2 Inflammation in Airway Diseases

Learn more

Hear from an expert on how do you manage treatment compliance issues in Patients with CRS with Nasal Polyps?

Learn more

Hear From An Expert On The Type 2 Immune Response And Inflammation

Learn more

Hear from an expert on what are the main challenges in treating Patients with CRS with Nasal Polyps?

Learn more

Do historical HbA1c values explain glycemic legacy effect in type 2 diabetes?

Learn more

Hear from an expert on how can you limit the effects of systemic steroid use for Patients with CRS with Nasal Polyps?

The superiority of Biologics over OCS for disease modifying potential which explains the superiority over OCS as anti-inflammatory option for our patients with CRSwNP, when we prescribe the Biologicals, we prescribe them long term for chronic disease where we do believe that we do not only aim to reduce inflammation but also to have some disease modifying effects.

Learn more

Rethink your Nasal Polyps. Type 2 Inflammation a Nasal Polyps mystery

Learn more

Type 2 Inflammation is the underlying cause of CRSwNP in 80% of Patients.

Learn more